UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000011104
Receipt No. R000013007
Official scientific title of the study Spectrum analysis of endobronchial ultrasound for the support of lymph node diagnosis during endobronchial ultrasound-guided transbronchial needle aspiration
Date of disclosure of the study information 2013/07/10
Last modified on 2017/01/05 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Spectrum analysis of endobronchial ultrasound for the support of lymph node diagnosis during endobronchial ultrasound-guided transbronchial needle aspiration
Title of the study (Brief title) Spectrum analysis of endobronchial ultrasound image
Region
Japan

Condition
Condition Intrathoracic adenopathy
Classification by specialty
Pneumology Chest surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To evaluate the clinical benefit of spectrum analysis of convex probe endobronchial ultrasound during endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) for the diagnosis of intrathoracic adenopathy.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes In comparing each spectrum parameter and pathological results, the primary outcome measures will be;
1) Sensitivity, 2) Specificity, 3) Positive predictive value, 4) Negative predictive value, 5) Accuracy in detecting nodal metastasis
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
90 years-old >=
Gender Male and Female
Key inclusion criteria candidate for EBUS-TBNA
Key exclusion criteria Inability to give informed consent.
Target sample size 250

Research contact person
Name of lead principal investigator Ichiro Yoshino
Organization Graduate School of Medicine, Chiba University
Division name Department of General Thoracic Surgery
Address 1-8-1, Inohana, Chuo-ku, Chiba
TEL 043-222-7171
Email tnakajima76@hotmail.com

Public contact
Name of contact person Takahiro Nakajima
Organization Graduate School of Medicine, Chiba University
Division name Department of General Thoracic Surgery
Address 1-8-1, Inohana, Chuo-ku, Chiba
TEL 043-222-7171
Homepage URL
Email takahiro.nakajima@chiba-u.jp

Sponsor
Institute Graduate School of Medicine, Chiba University
Institute
Department

Funding Source
Organization Self funding
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 千葉大学医学部附属病院

Other administrative information
Date of disclosure of the study information
2013 Year 07 Month 10 Day

Progress
Recruitment status Completed
Date of protocol fixation
2013 Year 05 Month 31 Day
Anticipated trial start date
2013 Year 07 Month 10 Day
Last follow-up date
2015 Year 12 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information In comparing each spectrum parameter and pathological results, the primary outcome measures will be;
1) Sensitivity, 2) Specificity, 3) Positive predictive value, 4) Negative predictive value, 5) Accuracy in detecting nodal metastasis

Management information
Registered date
2013 Year 07 Month 03 Day
Last modified on
2017 Year 01 Month 05 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000013007